Cancer remains one of the most threatening causes of human health impairment, and the mechanisms underlying tumorigenesis have not been completely characterized. MicroRNAs (miRNAs) are a group of endogenous, small (18~25 nucleotides) non-coding RNAs which negatively regulate gene expressions by directly binding to the 3'-untranslated regions (3'-UTRs) of the target messenger RNAs (mRNAs). Increasing evidence has demonstrated abnormal miRNA profiles and confirmed their involvement in tumor initiation and progression. As one important member of the miR-200 family, microRNA (miR)-141 is aberrantly expressed in many human malignant tumors, participating in various cellular processes including epithelialmesenchymal transition (EMT), proliferation, migration, invasion, and drug resistance. In the present review, we briefly describe the mechanisms underlying miR-141-mediated tumorigenesis and the possible future of miR-141 as a potential diagnostic and prognostic parameter as well as therapeutic target in clinical applications.
Introduction
Human cancers display a high level of heterogeneity, with clinical outcome ranging from spontaneous regression without treatment, to rapid disease progression and mortality. Despite of the development of new chemotherapies and molecular-targeted therapies, most patients experience recurrence, finally, succumb to the disease. Moreover, resistance to anticancer agents increasingly becomes the major clinical obstacle to successful treatment RNAi (RNA interference) enzyme complex [27, 28] . The duplex is unwound by helicase and the guide strand is loaded into RISC while the passenger strand is released. However, sequencing results of recent studies suggest that the passenger strand itself may also target gene expression [29, 30] . The RISC has been reported to down-regulate target genes by translational repression or mRNA cleavage [31, 32] . The specificity of miRNA targeting is defined by how complementary are the "seed" sequence (positions 2 to 8 of the 5' miRNA) and the "seed-match" sequence (generally in the 3' UTR of the target mRNA). A perfect match between miRNAs and mRNA sequences promotes the degradation of mRNAs by Ago1/2, while an imperfect match usually leads to translational repression [33] . So it is not surprising that one single miRNA is capable of binding to hundreds of mRNAs, while a single mRNA may have target sites for multiple miRNAs.
A Dual Role of MiR-141 in Human Cancers
Based on high-throughput techniques, a great deal of deregulated miRNAs were screened out in various human malignancies and suggested to possess oncogenic or tumor suppressive activities [34] . For instance, miR-141 is overexpressed in ovarian and NSCLC tissues, nasopharyngeal carcinoma, prostate cancer (PCa), classic papillary thyroid carcinoma, bladder cancer and colorectal cancers, while down-regulated in gastric cancer, pancreatic ductal adenocarcinoma, pancreatic cancer, osteosarcoma, prostate cancer, hepatocellular, primary peritoneal carcinoma, choriocarcinoma, esophageal cancer, breast cancer and renal cell carcinoma, raising a controversial issue about the role of miR-141 in cancer progression (Table 1) . Interestingly, dysregulation of miR-141 is depending on the type of cancers; in other words, miR-141 plays a dual role in tumorigenicity and can modulate cellular motility and control "stemness" [35] . This phenomenon strongly suggests that miR-141 is a core oncogene or tumor suppressor gene and provides new options for the targeting of cancer therapeutic agents.
Upstream and Downstream Pathways of MiR-141
There is an evolutionarily conserved signal transduction cascade involved in the control of many fundamental cellular processes (Table 2) . In this review, we briefly summarize the current knowledge concerning to the regulatory network of miR-141 ( Fig. 2-3 ) and discuss whether this novel regulation mechanism is conductive to get a new breakthrough in different human cancers.
Accumulating evidence shows that both genetic and epigenetic alterations can cause miRNA dysregulation [36] . And promoter hypermethylation is the best studied of the epigenetic changes [37] . It is well known that mammalian DNA is predominantly methylated at the C-5-position of complimentary CpG bp by DNA methyltransferases [38] . DNA methylation of CpG islands is also present in the promoter region of miRNAs with tumor suppressor features. For instance, anomalous DNA methylation of the miR-200c/miR-141 CpG island is strongly associated with their inappropriate silencing in cancer cells [39] . Furthermore, DNA methylation maintains the balance of tissue-specific expression of the miR-200c/141 cluster in normal cells and affects the phenotypic changes observed in cancer cells. Current findings indicate that downregulation of miR-200c and miR-141 is due to a highly methylated CpG island located upstream of their genomic sequence and/or upregulated transforming growth factor (TGF)-β signaling [40] . The double-negative feedback loop controlling ZEB1 is perhaps the best known mechanism of miR-200c/141 action. ZEB1 and ZEB2 expressions in gastric cancer tissue are higher than the matched adjacent tissues. In breast cancer, it is also indicated that the TGF-β/miR-200/ZEB signaling network regulates the establishment and maintenance of EMT [41] . Interestingly, it was reported that the transmembrane glycoprotein MUC1 could regulate miR-200c/141 expression in pancreatic cancer cells by decreasing transcript production at the promoter of miR-200c/141 as well as directly interacting with ZEB1, which is responsible for phosphorylation of the YEKV motif [42] .
Given that the number of target genes is still growing, there is a complicated regulatory network for miR-141.And by regulating those target genes, miR-141 exerts a dual role in tumorigenicity.It was demonstrated that P4 down-regulation of miR-141 could facilitate an increase in stem-like breast cancer cells [43] . Inhibition of miR-141 alone potentiated the CD44 high population and strengthened P4-mediated increases in both CD44 high and CK5 + cells. MiR-141 directly targeted both PR and Stat5a which is a sore of transcription factor important for MaSC expansion. Loss of miR-141 increased PR protein levels which was estrogen dependent even in cell lines. Furthermore, miR-141 depletion enhanced both mammosphere formation and tumor initiation. The mechanism controlling mammary cell fate by which P4-triggered loss of miR-141 aids in breast cancer cell de-differentiation through dysregulation of PR and Stat5a.
MiR-141 was also reported to play an osteosarcoma-suppressing role via ZEB1 and ZEB2 [44] . Liu et al. revealed that miR-141 could function as a tumor suppressor in HCC cells by targeting Tiam1 [45] . Besides, hepatocyte nuclear factor-3β protein levels were consistently upregulated in HCC clinical tissues compared with matched normal adjacent tissues. High expression of hepatoma-derived growth factor was positively associated with aggressive phenptypes of tumors including proliferation, angiogenesis, and poor prognosis of patients [46] . Chen et al. identified HDGF as a direct target of miR-141 in GC cells [47] . MiR-141 could also act as a tumor suppressor through directly targeting transcriptional co-activator with PDZ-binding motif and subsequent cell proliferation repression as well as cell invasion and migration inhibition in GC cells. Recently, kelch-like ECH-associated protein 1 was identified as a direct target of miR-141 in GC. Furthermore, miR-141 inhibited gastric cancer invasion via repression of STAT4. Therefore, the miR-141-STAT4 pathway may be exploited in a therapeutic approach for the treatment of H. Pylori related cancers [48] . Functional researches suggested that miR-141 could not only inhibit growth and colony formation but also enhance caspase-3-dependent apoptosis in pancreatic ductal adenocarcinomacells by targeting Yes-associated protein-1 [49] . In pancreatic cancer, another research demonstrated that miR-141 could directly bind to 3′-UTR of mitogenactivated protein kinase isoform 4 to inhibit MAP4K4 expression and lead to the inhibition of cell proliferation [50] . In esophageal cancer, inhibition of SRY-box containing gene 17 (SOX17) by miR-141 or by methylation both activated the WNT-signaling pathway and promoted esophageal tumorigenesis. Upon SOX17 restoration, TGF/β-catenin-dependent transcription and colony formation could be suppressed. MiR-141 was also expounded to induce cisplatin resistance through downregulation of YAP1 in human esophageal carcinoma [51] . In addition, Hu et al. reported that miR-141 could regulate Smad interacting protein 1 and inhibit migration and invasion of colorectal cancer cells [52] . Poell et al. also reported that miR-141 could inhibit the proliferation of melanoma cells [53] . And, Senanayake et al. found that miR-141 was down-regulated in renal childhood neoplasms, and targeted the activin receptor type 2B, which was a member of the TGF-β pathway [54] . Yu et al. showed that miR-141 was downregulated in human renal cell carcinoma and regulated cell survival by targeting CDC25B [55] . The transcriptional loss of miR-141 resulted in increased CDC25B expression which could increase genomic instability at an early stage of renal cell carcinoma development. Chen et al. also found that miR-141 was decreased in renal cell carcinoma via targeting erythropoietin-producing hepatocellular (Eph) A2 [14] . Functional enrichment analysis helped to elucidate that down-regulation of miR-141 and miR-200c in renal cell carcinoma are both involved in depression of CDH1/E-cadherin transcription via upregulation of ZFHX1B [56] .
Interestingly, dysregulation of miR-141 rests with the type of cancers; in other words, miR-141 plays a two-tier role in tumorigenicity sequentially modulate cellular motility. MiR-141 has been found to be upregulated in some cancers and act as an onco-miRNA. Zhang et al. suggested that the expression level of miR-141 was elevated in the serum of patients with bone-metastatic prostate cancer and positively correlated with more bone lesions [57] . Zhang et al. reported that miR-141 was up-regulated in NPC specimens in comparison with normal nasopharyngeal epithelium [58] . Either knockdown of oncogene c-MYC or re-expression of tumor suppressor gene SPLUNC1 exerted remarkable influences on the miRNA profiles in NPC. This discovery simultaneously identified BRD3, UBAP1 and PTEN as direct targets of miR-141. MiR-141 showed an inverse correlation to the protein expression of G-protein subunit a-13 in prostate cancer cells, and forced overexpression of miR-141 negatively regulated the invasion capability of prostate cancer cells [59] . Interestingly, Xiao et al. have found that Small heterodimer partner was a target of miR-141 and was downregulated in cultured human PCa cells with the involvement of upregulation of miR-141, which accelerated AR transcriptional activity [60] . Current research appears to validate such a view that miR-141 posttranscriptionally drops off BMI1 expression in human diploid fibroblasts by means of a miR-141 targeting sequence in the 3′-untranslated region of BMI1 mRNA [61] . To our surprise, miR-141 expression was actually up-regulated in NSCLC tissues [62] . It was subsequently reported that PH domain leucine-PHLPP1 and PHLPP2 as target genes of miR-141 were antagonists of PI3K/AKT signaling by firsthand dephosphorylating AKT, which played crucial roles in cell proliferation, survival, differentiation and migration [63, 64] . Most reported studies supported that the LIF-induced STAT3 activation in trophoblastic cells seemed to be vital for a series of cell functions. It's observed that Hashimoto thyroiditis epithelium could be distinguished from neoplastic follicular thyroid epithelium isolated from classic papillary thyroid carcinoma and control epithelium based on the relative expression of miR-141.
The Functions and Pathways Involving MiR-141 Targets
Considering the cancer type-depending dysregulation of miR-141, it is not surprising that miR-141 could play a dual role in tumorigenicity, functioning either as a tumor suppressor or promoter.
MiR-141 and EMT
As is well-known, EMT is a facilitator of tissue remodeling in many physiological progressions such as embryonic development, wound healing, tissue regeneration and organ fibrosis [65] . EMT is also a fatal early step in tumor metastasis formation by controlling the detachment of invasive cancer cells from the primary tumor [66] . During EMT, the phenotypical changes and the gain of invasive capacity are consequences of a cascade of events ultimately leading to the attenuation of cell-to-cell adhesion proteins, such as downregulation of E-cadherin and up-regulation of Vimentin [67] . Owing to their expressing proteases that allow them to pass through the underlying basement membrane and migrate, the cells become more invasive to start the multistep process of metastasis, or escape from apoptosis and senescence as wll as immunosuppression [68] . An ocean of growth factors, including TGF-β and its downstream effectors Ras and Src, are involved in EMT. During the past years, much work has been done to investigate the function of the miR-200 family in EMT of cancers. Data from renal cell carcinoma showed that the ErB signaling pathway was significantly regulated by miR-141, which played a significant role in the process of EMT [68] . Another study demonstrated that the miR-200 family, especially miR-141 and miR200a, held the ability of suppressing TGF-β1-induced renal tubular EMT through Smad pathway by targeting ZEB1 and ZEB2 [69] . As mentioned above, ZFHX1B/ZEB2 is a molecular target of miR-200 family members. ZFHX1B, also known as SIP1 and ZEB2, functions as a transcriptional repressor for CDH1/E-cadherin, and enforced over-expression of ZFHX1B induces Vimentin [70] .
Previous studies exhibited that forced expression of SPRR2a was a powerful inducer of EMT. Mizuguchi et al. depicted the role of acetyltransferases on the miRNA-200c/141 promoter and their effect on the epithelial/mesenchymal status of the cells [71] . They described that the deacetylase inhibitor TSA as well as P300 and PCAF can lead to a shift towards epithelial characteristics in HUCCT-1-SPRR2a cells. P300 belongs to the KAT3 histone acetyltransferases which has at least 400 interacting protein partners and P300 is also thought to be an anti-cancer gene as the potential of P300 to restrain cancer progression is linked to phenotypes including EMT [72, 73] . Both P300 and PCAF could act as cofactors of ZEB1 and form a P300/PCAF/ZEB1 complex on the miR200c/141 promoter. This special binding results in lysine acetylation of ZEB1 and a release of ZEB1 suppression on miR200c/141 transcription. Next disruption of P300 and PCAF interactions dramatically down regulates miR-200c/141 promoter activity, indicating a PCAF/P300 cooperative function in regulating the transcriptional suppressor/activator role of ZEB1. EMT seems to be the early stage of metastasis, but later, following extravasation, metastasizing cells settle in target tissue and undergo differentiation processes that relate MET [74] . MET processes are controlled by a network of transcriptional regulators and can be affected by posttranscriptional and posttranslational modifications. Another research suggested that during EMT, miR-141 expression was repressed in a dose-and time-dependent manner through upregulation of HIPK2 expression. Though reducing E-cadherin, HIPK2 gained aberrant expression to promote EMT. Then, co-transfection of miR-141 with the HIPK2 ORF clone partially inhibited EMT by restoring E-cadherin expression. These novel findings contribute to obtain the understanding of the role of miR-141 in regulating renal fibrosis via the TGF-β1/miR-141/HIPK2/EMT axis, where miR-141 down-regulates the expression of HIPK2 via direct interaction with the 3'-UTR of HIPK2. Taken together, in-depth understanding about the mechanisms of miR-200 family affecting cancer cell phenotypes, can be conducive to yield clarification of tumor progression as well as latent therapeutic targets.
MiR-141 and Cell Proliferation
Uncontrolled cell proliferation is the most significant characteristic of cancer cells. How fast a tumor grows helps to show how aggressive the tumor is and how likely it is to spread to other parts of the body. In addition, proliferation rate is also an important predictor of therapeutic sensitivity. The miR-200 family has been demonstrated to be overexpressed in PDAC cells with effect on cell proliferation enhancement [75] . Analogical results have been found in cholangiocarcinoma, ovarian carcinoma and choriocarcinoma [76] [77] [78] . However, overexpression of miR-141 was reported to significantly inhibit the proliferation of GC. Growth inhibitory effects of miR-141 are in part mediated through its downstream target gene TAZ. TAZ is a transcription cofactor also known by gene name WW domain-containing transcription regulator 1, which plays pivotal roles in EMT, cell growth and organ development [79, 80] . TAZ was recently proposed to endow self-renewal capacity to cancer stem cells and inversely correlated with miR-141 levels in the primary GC tissues. Therefore, it was concluded that the upregulation of TAZ induced by suppression of miR-141 contributed to tumor progression in GC. A previous study suggested that overexpression of miR-141 suppressed HCC cell growth and invasion via ZEB2 targeting. Moreover, miR-141 inhibited proliferation of osteosarcoma cell lines, so overexpression of ZEB2 could more significantly inhibit the osteosarcoma cells proliferation [44] . And as mentioned, miR-141 participants in a complex NPC-related oncogenes-tumor suppressor genes network contributing to NPC tumorigenesis where miR-141 inhibition can regulate the Rb/E2F pathway that is critical for normal cell cycle progression from G1 into S phase. Inactivating RB and E2F/DP transcription factors lead to transcription of a number of genes essential for DNA replication and entrance into S phase though exerting their transactivation activity [81] . BRD3, PTEN and UBAP1 have been demonstrated to act as direct targets of miR-141. BRD3 and UBAP1 are both involved in NPC carcinogenesis as confirmed through their previous studies and PTEN is a crucial tumor depressor in numerous tumor types. BRD3 is a potential nuclear transcription factor and belongs to a bromodomain family which negatively regulates Rb/E2F pathway [82] . Phosphorylation of AKT is negatively regulated by PTEN, which plays an particular role in the activation of cascade of different protein targets involved in cell growth, proliferation and invasion, and promote tumorigenesis [83] . MiR-141 helps to inhibit PTEN expression via increasing the AKT phosphorylation levels. Rb/E2F, JNK2 and AKT pathways have been underlying affected by inhibition of miR-141. This gene-miRNA network involves miR-141 and tumor-related genes c-MYC, SPLUNC1, BRD3, UBAP1 and PTEN, which may contribute to NPC development. Several bioinformatical tools suggested that UBAP1 protein was involved in conferring target specificity to multiple enzymes of the ubiquitination system. The ubiquitin-dependent pathway plays a decisive role in understanding the pathological states including abnormal cellular proliferation and tumor growth. The foregoing result that the expression levels of miR-141 in NSCLC were overtoped than those in normal tissues was amazing [84] . Mei et al. discovered that miR-141 expression was markedly up-regulated in NSCLC tissues, and its overexpression promoted NSCLC cell proliferation in vitro and tumor growth in vivo [62] . The molecular mechanisms by which miR-141 accelerated cell proliferation were further investigated. The antagonists of PI3K/AKT signaling, PHLPP1 and PHLPP2, are targets of miR-141. Re-introduction of PHLPP1 and PHLPP2 abrogated miR-141-induced proliferation of NSCLC cells. In line with the results, Leukemia inhibitory factor significantly downregulated miR-141. LIF is well known to induce tyrosine phosphorylation of signal transducer and activator of transcription 3 in a variety of trophoblast and choriocarcinoma cell lines where it induces invasiveness [85, 86] . Silencing of miR-141 inhibits proliferation of JEG-3 choriocarcinoma cells, while over-expression does not further induce proliferation.
Several miRNAs have been elucidated to regulate cell proliferation by targeting key intermediates in cell cycle progression. Among them, expression of the miR-200a/141 cluster results in G1 arrest attributed to aggrandized p27/Kip1 expression and reduced cyclindependent kinase 6 expression. However, expression of the 200bc/429 cluster decreases G1 population and induces G2/M phase arrest, in line with reduction of p27/Kip1 and upregulation of the inhibitory phosphorylation of Cdc25C, respectively. In pancreatic cancer cells, up-regulating miR-141 by targeting MAP4K4, inhibited cell proliferation, clonogenicity, and induced G1 arrest [87] . MAP4K4 belongs to the mammalian STE20/MAP4K family, which is associated with cell motility, rearrangement of the cytoskeleton, and cell growth Gao et [88] . Moreover, miR-141 could promote G1/S phase transition of NSCLC cells in vitro and tumor growth in vivo, comfirming the oncogenic role of miR-141.
MiR-141 and Apoptosis
Apoptosis is recognized as the process of programmed cell death that may occur in multicellular organisms. In living organisms, apoptosis can cause disastrous effects, often in the form of disease, disorder or cancer. Therefore, the balance of anti-apoptotic and proapoptotic effectors in favor of deciding the damaged cells continue to replicate or to die. As a consequence, blocking of apoptosis in cells that are gaining oncogenic mutations can lead to tumor progression.
Several studies have shown that the miR-8-null fly, which was the Drosophila homolog of human miR-200 family, revealed increased apoptosis in the brain and smaller body size compared with wild types [89] . More importantly, overexpression of YAP1 could rescue not only the downregulation of YAP1 but also the growth inhibition and caspase-3-dependent apoptosis enhancement in PANC-1 cells induced by miR-141 upregulation [90] . YAP1 was first identified by virtue of its ability to associate with the SH3 domain of Yes-and Srcprotein-tyrosine kinases [91] . The assays demonstrated that the expression of miR-141 was inversely correlated with YAP1 protein in PDAC tissues. Overexpression of miR-141 could not only inhibit osteosarcoma cell proliferation but also induce cell apoptosis via ZEB1 and ZEB2 targeting [44] . In NPC, BRD2 and BRD3 interacted with BRD7 and played distinct roles in regulating cell apoptosis. In pancreatic cancer cells, miR-141 targeted MAP4K4, acting as a tumor suppressor which helped to induce apoptosis [87] . Some researchers demonstrated a significant increase in Shp expression and a marked reduce of miR-141 (both mature miR-141 and pri-miR-141) after PEITC treatment in LNCaP cells. Shp is an atypical member of the steroid/thyroid hormone nuclear receptor family of transcription factors and identified as an vital transcriptional co-repressor and metabolic regulator [92] . PEITC is a natural component of the organic isothiocyanates existing in the cruciferous vegetables and displays anti-proliferative effects on PCa and preneoplastic cells. Ulteriorly, PEITC could inhibit AR transcriptional activity in PCa cells, manifesting in respects containing inhibition of cytochrome P450 enzymes, reactivation of oxygen species production, and induction of apoptotic cell death [93] [94] [95] . MiR-141 is also involved in the PI3K/AKT signaling, where AKT plays a crucial role in holding the balance between proliferation and quiescence, as well as cell survival and apoptosis [96] . The downregulation of miR-141 can promote apoptosis in HepG2 cells during HCC carcinogenesis, at least partially, by modulation of HNF-3β [97] .
MiR-141 and Tumor Invasion and Metastasis
It is theorized that metastasis always coincides with a primary cancer, and, as such, is a tumor that started from a cancer cell or cells in another part of the body. However, over 10% of patients presenting to oncology units will have metastases with no primary tumor detected. Treatment and prognosis are determined, to a great extent, by whether the tumor remains localized or not. Malignancies allow for invasion into the circulation, followed by invasion to a second site for tumorigenesis. Several studies have exploited potential strategies that can prevent or at least slow down the spread of cancer by somehow blocking the two steps [98] . Metastasis is a complex process and the leading cause of cancer-related deaths. Reinforcing the understanding of the underlying mechanisms could be conducive to facilitating the development of effective metastasis-targeted therapies and improving the overall prognosis.
It was reported that the expression of miR-141 was significantly correlated with a more aggressive phenotype in clinic [49] . That is to say, miR-141 suppressed in vitro migration and invasion of GC cells. HDGF, which encoded high mobility group protein 1-like 2 protein, was identified as a target of miR-141 in GC cells [47] . HDGF expression gradually increased in the GC carcinogenesis process and had a higher level in poorly differentiated adenocarcinoma cells prone to lymphoid metastasis. HDGF overexpression significantly activated Erk1/2 in gastric epithelial cells and promoted anchorage-independent growth [99] , partially attenuating the suppressive effect of miR-141. Moreover, the negative correlation between miR-141 and its target was verified in patients and xenograft mice. Overexpression of miR-141 suppressed tumor growth and pulmonary metastasis in nude mice. In clinical samples, the expression of miR-141 was inversely correlated with TNM stage, tumor invasion depth, tumor embolus and disease-free survival [40] . Further study indicated that the miR-200c and miR-141 cluster (miR-200c/141) could inhibit migration and invasion of gastric cancer by directly targeting of ZEB1 and ZEB2 and the subsequent restoration of E-cadherin [100] . Others also found that miR-141 was decreased in renal cell carcinoma, inhibiting the migratory and invasive properties by ZEB2 suppression [101] . In addition, miR-141 played a pivotal role in getting command of gastric cancer invasion through regulating signal transducer and activator of transcription 4, which was a critical accelerator of gastric cancer metastasis and widely up-regulated in many carcinomas [102] . MiR-141 acted as an oncogene to influence NPC cell cycle, migration and invasion by positive regulation of Rb/E2F and AKT pathways. Current findings indicated that methylation of the miR-200c/141 promoter led to shutdown of promoter activity, while treatment with demethylating agents caused transcriptional reactivation of miR-200c and miR-141 in breast cancer cells. In addition, DNA methylation of miR-200c/141 promoter was closely correlated with the invasive capacity of cancer cells [67] . In breast cancer, all the members of miR-200 family were involved in EGF-driven invasion, and the miR-200bc/429 cluster showed stronger effects than the miR-200a/141 cluster. MiR-141 was down-regulated in HCC tissues, functioning as a tumor suppressor by inhibition of the migration and invasion of HCC cells via direct targeting of the metastasis-related gene Tiam1 [103] . Tiam1 is a member of the Dbl family of guanine nucleotide exchange factor that can affect small G proteins of the Rho family. MiR-141 inhibited HNF-3 β expression, subsequently inhibiting cell invasion in HepG2 cells. HNF-3 β belongs to the HNF-3/forkhead family of transcription factors in mammals and plays important roles in hepatocyte differentiation and HCC development. Studies have suggested miR-141 as a potential link between the HNF-3 β regulatory pathway and HCC and highlighted the importance of miR-141 as a tumor suppressor in HCC via suppression of HNF-3β translation [97] . It was demonstrated that miR-141 downregulated TM4SF1 expression and inhibit the metastatic potential of PC cells with no effect on cell proliferation, cell cycle progression or apoptosis [103] . As a member of the tetraspanin superfamily, TM4SF1 is a tumor-specific antigen unduly expressed in most of human cancers including lung, breast, colon, ovarian, renal, pancreatic and prostate carcinomas, and weakly expressed in normal vascular endothelium [104] .
As a novel biomarker for PCa, plasma miR-141 level can be used to screen for metastatic PCa with high sensitivity [105] . Skeleton is the most common metastatic organ in patients with PCa. It was reported that serum miR-141 levels were increased in patients with bonemetastatic PCa and that patients with higher levels of miR-141 suffered more bone lesions. In addition, serum miR-141 levels were correlated to serum ALP levels but not serum PSA levels. It is illustrated that miR-141 and miR-375 are induced and increasingly released into incubation medium from androgen-stimulated LNCaP cells. Chondrosarcoma is one of malignant bone tumors and has a tendency of local invasion and distant metastasis [106] . A traditional Chinese remedy named Paeonol (2'-hydroxy-4'-methoxyacetophenone) was proved to be capable of inhibiting chondrosarcoma cell migration and invasion though upregulation of miR-141 via PKC and c-Src pathways [107] .
MiR-141 and Angiogenesis
All blood vessels are lined by the vascular endothelium, and endothelial cells are key regulators of different aspects of vascular biology including the formation of new blood vessels (angiogenesis) [108] . Dysregulation of the vasculogenesis and angiogenesis pathological processes contributes to development of many diseases, including diverse as cancer, macular degeneration, psoriasis, diabetic retinopathy, thrombosis, and inflammatory disorders including arthritis and atherosclerosis [108] . Angiogenesis is controlled by physical interactions between cells and extracellular matrix as well as soluble angiogenic factors, such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF) families, bind to membrane-bound receptors and transmit signals through kinase-dependent signaling cascades [109, 110] . Recent studies have illustrated that a novel potential mechanism of endothelial cells regulation may be through the use of miRNAs. With regard to the anterior research, Mateescu et al. have issued that miR-141 overexpression was related to higher blood vessel formation in ovarian tumors of mouse models [77] . The vascular network is required for the expansion of tumor masses, as inhibition of new vessel formation prevents tumor growth. In addition, Tejero et al. examined the potential impact of the angiogenesis mechanism on the prognostic role of miR-141 in NSCLC [111] . The in vitro angiogenesis role of miR-141 was related to reduction of KLF6 protein levels, increasing the secretion of VEGFA. What's more, they observed that tumors with high levels of miR-141 had a higher number of blood vessels. It has been revealed that overexpression of miR-141 would lead to overproduction of VEGF-A and increased neoangiogenesis in NSCLC [112] .
MiR-141 and Tumor-Associated Virus
Hepatitis C virus (HCV) infection is prevalently considered a major cause of chronic liver disease and HCC. Accumulating evidence has indicated a direct role of miR-141 in the induction of HCV (1a, 1b, and 2a) -infected primary human hepatocytes by DLC-1 targeting. Identified as a candidate tumor suppressor gene by encoding a Rho GTPase-activating protein, DLC-1 gene was located in chromosome 8p21.3-22 [113] , which was frequently deleted in solid tumors including HCC. The GTPase activity of DLC-1 was specific for RhoA, a member of the Ras family of oncogenes [114] . It was reported that effective HCV replication was correlated with miR-141-mediated suppression of DLC-1 [115] , suggesting tumor suppressor genes can influence oncogenic virus replication by negatively regulating prooncogenic signaling proteins. HCV replication can be inhibited after depletion of miR-141 with oligonucleotides, whereas accelerated by artificial elevation of intracellular miR-141. The enhanced cell proliferation in HCV-infected hepatocytes can be countered by depletion of DLC-1 via miR-141 introduction. This novel mechanism of HCV infection-associated miRNAmediated regulation of a tumor suppressor protein has offered us with new strategies to intervene in cell proliferation of HCV infection-mediated liver cancer.
MiR-141 and Long Non-Coding RNAs
Long non-coding RNAs (lncRNAs) has been shown that it acts a role in the recruitment of chromatin modifying complexes and can influence gene expression .However, lncRNAs are not translated into proteins and were primitively deemed to be part of the 'dark matter' of the genome [116] . Recently, emerging evidence shows that lncRNAs are involved in almost all sorts of disease states including oncogenesis. It was recently reported that lncRNA HOTAIR could interact with the polycomb repressive complex and suppress its target genes to accelerate malignancy [117] . HOTAIR is located in the HOXC gene cluster and capable of enhancing H3K27 trimethylation to decrease expression of multiple genes as well as interacting with PRC2 (polycomb repressive complex 2) [118] . HOTAIR expression has closed correlation with cancer cell invasiveness, cell proliferation, cell cycle progression, and escape from apoptosis [119] . Furthermore, an inverse correlation between HOTAIR and miR-141 expressions was implied in renal carcinoma cells. Chiyomaru et al. suggested that miR-141 could suppress HOTAIR expression in an immunoprecipitated Ago2 -de-pendent manner and restrain HOTAIR functions in cell proliferation and invasion [117] . Also, it was reported that the interaction between miR-141 and lncRNA-H19 in regulating cell proliferation and migration in gastric cancer [120] . These results suggest that the interaction between lncRNA and miRNA will provide a novel element of control in gene regulation.
MiR-141 and Tumor-Associated Oxidative Stress Responses
Current findings indicate that redox regulation has an indispensable role in malignancies. Accumulation of reactive oxygen species (ROS) in tumor cells could damage the cellular [124, 125] . Interestingly, a resensitization effect towards paclitaxel, a ROS-producing therapeutic agent, was also observed upon miR-141 and miR-200a introduction, suggesting the potential of oxidative stress signature as a predictive and prognostic parameter. In ovarian tumor, the miR-200s were shown to be highly expressed in localized tumor and downregulated in metastases, defining a two-stage model of miR-200 expression [126, 127] . In conclusion, the interaction between miR-141 and cancer-associated oxidative stress response may afford new insight into overcoming resistance of antioxidant supplementation in clinic cases.
MiR-141 in Cancer Diagnosis and Prognosis
To improve the diagnosis and prognosis accuracy of different cancer entities, ongoing efforts have been made in identifying new biomarkers. Emerging evidence suggested that specific miRNA profiles were capable of distinguishing malignant and non-malignant tissues [128] , raising the feasibility of miRNAs in early detection of cancer, prognosis informing, and treatment response monitoring. It was reported that the expression level of miR-141 in PDAC tissues was significantly lower than that in corresponding nontumorous tissues [90] . Downregulation of miR-141 correlated with poorer pT and pN status, advanced clinical stage, lymphatic invasion, and shorter overall survival, suggesting that miR-141 was an independent prognostic factor for PDAC patients. Further study indicated that miR-141 functioned as a tumor suppressor gene in PDAC by direct targeting of YAP1. Similar prognostic roles of miR-141 were also detected in pancreatic cancer [87] . In bladder cancer, overexpression of miR-141 occurred more frequently in the bladder cancer tissues with high tumor stage and tumor grade (WHO 2004) and low invasiveness. Wszolek et al. suggested miR-141 upregulation as an independent indicator for favorable prognosis of bladder cancer [129] . In a previous study, miR-141 expression level was proved to be negatively associated with the gastric cancer marker CA724, which was also a valuable prognostic factor. Another study revealed the close correlation between elevation of plasma miR-141 and stage IV colon cancer in a cohort of 102 plasma samples. Moreover, miR-141 expression differed not only in tumor tissues between Stage IV and Stage I-II colon cancer patients but also in tumor tissues and adjacent non-tumor tissues of Stage IV patients. In addition, the combination of miR-141 and carcinoembryonic antigen, a widely used marker for colorectal cancer, helped to boost the detection accuracy of distant metastasis in colon cancer [130] . Interestingly, a high level of miR-141 expression was demonstrated to be associated with both benign and poor prognosis in ovarian cancer [131] .
Growth of early stage PCa is androgen-dependent [132] . The serum prostate-specific antigen test along with digital rectal examination have been widely used in detection of early stage PCa. Serum PSA test is also used to monitor PCa recurrence after a set of therapies [133] . Agaoglu et al. 2011 , reported that circulating miR-21, miR-141 and miR-221 could help to distinguish PCa patients with metastasis from those with local advanced disease [134] . Among the three miRNAs, miR-141 was the most powerful discriminator of metastatic PCa, indicating the potential of miR-141 as a supplement to PSA testing in clinical application. Distinct from the previous result, no significant difference in miR-141 expression was observed between the patient group and healthy controls. Recent studies revealed that PEITC could inhibit AR transcriptional activation through downregulation of miR-141 and upregulation of Shp in PCa cells, suppressing PCa growth both in vitro and in vivo and reducing the risk of tumorigenesis in animal models [135] [136] [137] . MiR-141 downregulation could also attenuate dihydrotestosterone-induced transcription of PSA gene. Besides, circulating miR-141 was identified as a novel diagnostic and prognostic biomarker across several other independent studies [138] [139] [140] . Interestingly, miR-141 functioned in an androgen dosedependent manner in AR positive cell lines [141] .
A specific miRNA expression signature including miR141 was previously reported to be helpful in differentiating papillary thyroid cancer cell lines from the control thyroid cell line [142] . Further investigation of miR141 regulatory networks contributed to elucidate the molecular mechanisms involved in the fundamental physiological differences among the malignant thyroid phenotypes such as classic PTC, follicular variant PTC, follicular thyroid carcinoma and Hashimoto thyroiditis. HT samples displayed noticeable downregulation of miR141 in comparison with cPTC and control thyrocytes. The downregulation of miR141 was due to its involvement in TGF-β pathway, which played important roles in T-cell autoimmunity and had close association with HT through cytokine interleukin-2 regulation. Moreover, a subset of TGF-β pathway members were demonstrated to be direct targets of miR-141, such as TGF-βR1 and SMAD family member 2, which were upstream regulatory factors of IL-2 [143] . MiR-141 can also be a potential biomarker for the molecular diagnosis and risk stratification in NSCLC. MiR-141 was reported to be upregulated in NSCLC tissues compared with the corresponding normal ones by several independent studies [62, 84, 144] . This excessive expression of miR-141 was further proved to be associated with the larger tumor size, lymph node metastasis and advanced stage in NSCLC patients. Interestingly, the correlation of miR-141 upregulation and shorter overall survival was only detected in adenocarcinoma, but not squamous cell carcinoma.
MiR-141 in Cancer Treatment
Resistance to anticancer agents remains a major obstacle to successful treatment of cancer in clinic, and the mechanisms have been extensively investigated at both levels of genes and proteins [145] . Recent reports indicate that miR-141 expression level is correlated with the response of cancer patients to both chemotherapy and molecular-targeted therapy. Cisplatin is the most commonly used anti-tumor chemotherapy agent. Mechanisms of cisplatin resistance include increasing inactivation of cisplatin compounds by glutathione, decreasing accumulation in cells, inactivation of apoptosis pathways and alterations in the repair of DNA lesions. Imanaka et al. 2011 , showed that miR-141 could confer resistance to cisplatininduced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma [51] . In esophageal cancer cell lines, both miRNA-141 targeting and promoter hypermethylation could inhibit SOX17 functions and promote tumorigenesis through wnt-signaling activation [10] . Interestingly, H. pylori infection was reported to significantly down-regulate miR-141 expression and ulteriorly modulate cisplatin sensitivity through miR-141-mediated regulation of KEAP1 [146] . KEAP-1 overexpression could transcriptionally inactivate NRF-2, thus playing key roles in transcriptional regulation of oxidative stress which may protect cancer cells from chemotherapeutic agents and facilitate cancer progression [147] . Moreover, overexpression of miR-141 activated NF-kB signaling pathway through KEAP1 suppression, while that inhibition of this pathway partially reverses miR-141-mediated cisplatin resistance [16] . Notably, miR-141 levels appeared to be higher in resistant than in sensitive non-serous ovarian tumors, proposing that the relationship between miR-141 and therapy response may be histological-dependent. By targeting MAP4K4, miR-141 could partially enhance the chemosensitivity of PANC-1 and MiaPaCa-2 pancreatic cancer cells to 5-FU and gemcitabine. Treatment with the DNA methyltransferase inhibitor (decitabine) could ameliorate miR-200c/141 downewgulation induced by TGF-β in SGC-7901 gastric cancer cells. Besides, miR-141 was also capable of regulating target genes such as p38a, YAP1 etc., highlighting the role of miR-141 as a core factor in the response to chemotherapeutics. As for targeted therapy, Berkers et al. reported that miR-141 downregulation-driven EMT in clear cell renal cell carcinoma was correlated to an unfavorable response to sunitinib therapy, and reintroduction of miR-141 in vitro led to EMT reversal and increased sensibility to a hypoxic environment [148] . Also, polycomb group protein BMI1 is an vital regulator of aging, senescence and cancer [149] . With the ability of causing bypass of senescence and immortalization of certain epithelial cell types [150, 151] , BMI1 is required for self-renewal of stem cells and is often over-expressed in cancer cells. It was discovered that in HDFs, overexpression of miR-141 led to premature senescence via BMI1 targeting and consequence activation of p16INK4a, p53 and p21 in normal but not in exogenous BMI1-overexpressing cells.
Conclusions for preventing cancer
Mounting evidence suggests that miRNAs are critical regulators of multifarious diseases including cancer and could be utilized as novel biomarkers for cancer diagnosis, prognosis and treatment. In this review, we described the convincing data presenting miR-141 dysregulation in human malignancies and the mechanisms underlying miR-141-mediated tumorigenesis, such as EMT, proliferation, apoptosis, and metastasis [152] [153] [154] . Intriguingly, miR-141 could play a dual role as either an oncogene or a tumor-suppressor gene in tumorigenicity of various cancers upon the context. We also discussed the momentous promise of miR-141 as a potential diagnostic and prognostic parameter as well as therapeutic target in personalized therapies of human cancers.
Despite development of early screening and new chemotherapeutic strategies, cancer survival rates achieved no substantially improvement during the past decades. Sensitive and non-invasive biomarkers that can facilitate disease detection, staging, monitoring and prediction of therapeutic outcomes are highly desirable to improve survival rate and help to determine optimized treatment. The time-and pathological-specific expression has raised the possibility of using miR-141 as a novel biomarker from cancer diagnosis to treatment. Meanwhile, therapeutic approaches to introduce miR-141 into manifold cancer cells might be potentially feasible, not only for prohibiting the development of tumorigenes but also in sensitizing cancer cells to chemotherapeutic in the future. Considering the complexity of miR-141 network which involves a variety of signaling pathways, the identification of functional targets needs further verification in more tumor types and clinical tissue samples before the proper application of miR-141 as a molecular biomarker in human cancers. Gao 
